Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Nicholas J. Vogelzang Michael A. Carducci Celestia Higano Catherine M Tangen |
| Publication date | 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |